Report DMCA Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokineti
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.